0001123292-18-000972.txt : 20180924 0001123292-18-000972.hdr.sgml : 20180924 20180924163248 ACCESSION NUMBER: 0001123292-18-000972 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180901 FILED AS OF DATE: 20180924 DATE AS OF CHANGE: 20180924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bertolino Arthur Peter CENTRAL INDEX KEY: 0001426344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37357 FILM NUMBER: 181083864 MAIL ADDRESS: STREET 1: C/O INNOVATION PHARMACEUTICALS INC. STREET 2: 100 CUMMINGS CENTER, SUITE 151-B CITY: BEVERLY STATE: MA ZIP: 01915 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innovation Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001355250 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134303398 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 100 CUMMING CENTER STREET 2: SUITE 151-B CITY: BEVERLY STATE: MA ZIP: 01915 BUSINESS PHONE: 978-921-4125 MAIL ADDRESS: STREET 1: 100 CUMMING CENTER STREET 2: SUITE 151-B CITY: BEVERLY STATE: MA ZIP: 01915 FORMER COMPANY: FORMER CONFORMED NAME: Cellceutix CORP DATE OF NAME CHANGE: 20080515 FORMER COMPANY: FORMER CONFORMED NAME: EconoShare, Inc. DATE OF NAME CHANGE: 20060306 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-09-01 0001355250 Innovation Pharmaceuticals Inc. IPIX 0001426344 Bertolino Arthur Peter C/O INNOVATION PHARMACEUTICALS INC. 100 CUMMINGS CENTER, SUITE 151-B BEVERLY MA 01915 0 1 0 0 President and CMO Class A Common Stock 2018-09-01 4 A 0 1066667 0 A 2699873 D Employee Stock Option (right to buy) .398 2018-09-01 4 A 0 617839 0 A 2028-09-01 Class A Common Stock 617839 617839 D The restricted stock and stock options vest upon the earliest of (i) 50% on September 1, 2019 and 50% on September 1, 2020; (ii) the Company's common stock closes above $3.00 per share (as may be adjusted for any stock splits or similar actions); (iii) the commencement of trading of the Company's common stock on a national securities exchange; or (iv) upon a change of control of the Company, as defined in the Company's 2016 Equity Incentive Plan. /s/ Arthur P. Bertolino 2018-09-24